Found 1273 matching trials
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
N/AThis is a single cohort observational safety study. All patients will be tr...
Location
Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie
NBE-002 in Patients With Advanced Solid Tumors
PHASE1This first-in-human study will evaluate the recommended dose for further cl...
Location
Sarah Cannon Research Institute - TN Oncology
A Study of SY-1365 in Adult Patients With Advanced Solid Tumors
PHASE1This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Location
University of Alabama at Birmingham
AVAREG Study: An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer
N/AThis multicenter, single-arm observational study will evaluate the clinical...
Location
Multiple Locations
ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib
PHASE3This study was originally designed as a Phase III randomized, double blind,...
Location
Novartis Investigative Site
Assessing the Time Demands of Cancer
N/AA total of 80 individuals receiving treatment for metastatic breast or adva...
Status
Active Not Recruiting
Location
University of Alabama
Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer
PHASE2This study is a prospective, open-label, randomized, multicenter, two-cohor...
Location
The Second Affiliated Hospital of Dalian Medical University
Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery
N/APre-existing pain and severe postoperative pain are predictors of persisten...
Status
Active Not Recruiting
Location
Duke University Medical Center
Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer
PHASE1The purpose of this research study is to determine how well pertuzumab and ...
Location
Duke University Medical Center
Utilization of Genomic Signature as Decision-making for Adjuvant Treatment of Breast Cancer
NAMethod: This multicentric prospective cohort is composed of patients with n...
Location
Centre Léon BERARD